Inside Investor Relations


New NIRI chair’s top priority

Comments (0) | 5 Oct 2011 | RatingRating (-1 to +1): 0.0 | Print

Derek Cole of ARCA biopharma is focused on implementing NIRI's new strategic plan


The newly elected chairman of the NIRI board of directors, Derek Cole, says his top priority for his one-year term will be to initiate implementation of the NIRI strategic plan, due to be voted on and released by the end of this year.

Cole is vice president of IR and ...

Register now to read the rest of this article! Registration is free and you will be able to read five articles every month.

Become a subscriber for unlimited access.

Read More About Topics

More on sectors in this article

More on companies in this article

Featured Articles

Print magazine
All the articles from the May edition of
IR magazine
More

Technology
Walmart launches a new IR app plus
a video-heavy annual report
More

IR societies
How the Netherlands’ IR association
has promoted IR for 20 years
More